Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Borregaard ASA: EBITDA1 of NOK 515 million in the 2nd quarter

BRGRegulatory press release16.07.2026 klo 08.00

Borregaard’s operating revenues increased to NOK 2,114 million (NOK 2,045 million) in the 2nd quarter of 2026. EBITDA1 was NOK 515 million (NOK 522 million). The result in BioMaterials and Fine Chemicals increased, while BioSolutions had a lower result compared with the 2nd quarter of 2025.

In BioSolutions, higher sales volume was more than offset by higher energy and energy-related costs, negative currency effects, and a less favourable product mix. For BioMaterials, high deliveries of speciality cellulose were partly offset by lower sales prices and a weaker product mix. A record production contributed positively to the result. In Fine Chemicals, higher deliveries and a favourable product mix were the main reasons for the improved result. Net currency effects were slightly positive for the Group.

Wood costs were approximately 15% lower compared with the 2nd quarter last year. The Middle East conflict had a negative impact on Borregaard's energy, logistics and chemical costs. The net cost impact on raw materials, energy and logistics was approximately NOK 40 million compared with the 2nd quarter 2025.

Borregaard is implementing a cost improvement programme targeting annual savings of NOK 150 million. The savings will be realised gradually, with full effect from 2028.

Other income and expenses were NOK -30 million related to ground stabilisation measures at the Sarpsborg site.

In the 2nd quarter of 2026, Borregaard has made an impairment of NOK 337 million of its investments in Alginor ASA. The impairment is recorded as part of financial items.

Profit before tax was NOK -45 million (NOK 326 million). Earnings per share were NOK -1.27 (NOK 2.56). Excluding ground stabilisation measures and impairment of Alginor, earnings per share were NOK 2.35.

“We are pleased to deliver a strong result in a challenging business environment. The quarter once again demonstrates the resilience of Borregaard’s highly diversified portfolio and broad customer base”, says CEO Tom Erik Foss-Jacobsen.

Contacts:
Director Investor Relations, Pål Espen Ramberg, +47 959 17 333
Director Communications, Tone Horvei Bredal, +47 924 67 711

1. Operating profit before depreciation, amortisation and other income and expenses
2. Figures in parentheses are for the corresponding period in the preceding year

This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5 – 12 of the Norwegian Securities Trading Act.

This stock exchange announcement was published by Lotte Kvinlaug, Investor Relations Officer at Borregaard ASA, on 16 July 2026 at 07:00 CEST.

Attachments

  • 2nd quarter 2026 presentation
  • 2nd quarter 2026 report
  • Quarterly and accounting figures 2nd quarter 2026